文献速递基础与转化研究组学、生物样本库与精准医学

BATF是急性髓系白血病中NK细胞表观遗传重编程及功能障碍的主要驱动因子

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.
PubMed 文献 · Sci Transl Med · 2024-09-11

研究揭示骨髓增生异常综合征和急性髓系白血病患者NK细胞存在杀伤功能受损、代谢改变及耗竭表型,该功能障碍由NK细胞与髓系原始细胞接触介导,经αvβ-整合素/TGF-β/SMAD通路诱导BATF表达,BATF结合HAVCR2、LAG3、TIGIT和CTLA4等耗竭相关基因,导致表观遗传重编程使功能障碍持续存在,敲除BATF可在体外和体内增强NK细胞抗白血病功能。

要点

  • NK细胞功能障碍需与髓系原始细胞直接接触,由αvβ-整合素/TGF-β/SMAD通路介导。
  • BATF受SMAD2/3直接调控,结合HAVCR2、LAG3、TIGIT和CTLA4等耗竭相关基因。
  • 敲除BATF可在体外和体内增强NK细胞抗急性髓系白血病功能。

核心结论

  • 研究揭示急性髓系白血病中NK细胞免疫逃逸的新机制,即髓系原始细胞通过表观遗传重编程使NK细胞失活。

研究设计与样本

  • 研究纳入骨髓增生异常综合征和急性髓系白血病患者来源的NK细胞,采用单细胞转录组和蛋白质组分析,并进行体外和体内功能实验。

主要发现

  • 患者NK细胞表现为杀伤能力受损、代谢改变及单细胞转录组和蛋白质组水平的耗竭表型。
  • NK细胞功能障碍由NK细胞与髓系原始细胞接触介导,靶向αvβ-整合素/TGF-β/SMAD通路可预防功能障碍,但一旦建立则因深度表观遗传重编程而持续存在。
  • BATF被鉴定为核心转录因子和急性髓系白血病中NK细胞功能障碍的主要介质,受SMAD2/3直接调控并诱导,结合HAVCR2、LAG3、TIGIT和CTLA4等耗竭相关基因。
  • 敲除BATF可在体外和体内增强NK细胞抗急性髓系白血病功能。

关键数值与推荐

  • 靶向αvβ-整合素/TGF-β/SMAD通路可预防NK细胞功能障碍。
  • BATF缺失可增强NK细胞体外和体内抗急性髓系白血病功能。

临床怎么用

  • 作者认为,使用健康异体NK细胞过继细胞疗法治疗髓系恶性肿瘤时,应联合靶向TGF-β通路或BATF以预防NK细胞功能障碍的策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelodysplastic syndrome and acute myeloid leukemia (AML) belong to a continuous disease spectrum of myeloid malignancies with poor prognosis in the relapsed/refractory setting necessitating novel therapies. Natural killer (NK) cells from patients with myeloid malignancies display global dysfunction with impaired killing capacity, altered metabolism, and an exhausted phenotype at the single-cell transcriptomic and proteomic levels. In this study, we identified that this dysfunction was mediated through a cross-talk between NK cells and myeloid blasts necessitating cell-cell contact. NK cell dysfunction could be prevented by targeting the αvβ-integrin/TGF-β/SMAD pathway but, once established, was persistent because of profound epigenetic reprogramming. We identified BATF as a core transcription factor and the main mediator of this NK cell dysfunction in AML. Mechanistically, we found that BATF was directly regulated and induced by SMAD2/3 and, in turn, bound to key genes related to NK cell exhaustion, such as HAVCR2, LAG3, TIGIT, and CTLA4. BATF deletion enhanced NK cell function against AML in vitro and in vivo. Collectively, our findings reveal a previously unidentified mechanism of NK immune evasion in AML manifested by epigenetic rewiring and inactivation of NK cells by myeloid blasts. This work highlights the importance of using healthy allogeneic NK cells as an adoptive cell therapy to treat patients with myeloid malignancies combined with strategies aimed at preventing the dysfunction by targeting the TGF-β pathway or BATF.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Kumar B, Singh A, Basar R, et al. BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML. Sci Transl Med. 2024. PMID: 39259809. doi:10.1126/scitranslmed.adp0004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。